FDA Drug recall D-0150-2020
Amino Acid Injection 50 g/1000 mL (50 mg/mL) 25 g L-Arginine HCl
- FDA Drug
- Class II
- terminated
- Published 2019-10-30
On 2019-10-30 the FDA classified a Class II recall of Amino Acid Injection 50 g/1000 mL (50 mg/mL) 25 g L-Arginine HCl by Nephron Pharmaceuticals, citing lack of Assurance of Sterility; bags have potential to leak.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0150-2020 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2019-10-09 |
| Published | 2019-10-30 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Nephron Pharmaceuticals |
| Distribution | US |
Product
Amino Acid Injection 50 g/1000 mL (50 mg/mL) 25 g L-Arginine HCl; 25 g L-Lysine HCl, Single Dose Container, Rx Only Nephron 503B outsourcing facility 4500 12th St. Extension West Columbia, SC 29172 NDC: 69374-988-10
Reason
Lack of Assurance of Sterility; bags have potential to leak
Identifiers
| code_info | Lots: AA9023A Exp. 10/24/2019; AA9023B Exp. 10/24/2019 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Other recalls by Nephron Pharmaceuticals
- PF-Succinylcholine Chloride Injection, USP 20 mg/mL (200 mg/10 mL), Rx Only, Single-Dose Container, 5 x 10 mL pre-filled syringes, Nephron…
FDA Drug · Class III · 2019-11-06 · Nephron Pharmaceuticals - PF-Fentanyl Citrate (2 mcg/mL)* & Bupivacaine HCl 0.0625 in 0.9% Sodium Chloride Injection-250 mL Total Dose: (500 mcg/156.3 mg)/250 mL, Rx…
FDA Drug · Class II · 2019-10-30 · Nephron Pharmaceuticals - PF-Fentanyl Citrate 2 mcg/mL* & Bupivacaine HCl 0.125% in 0.9% Sodium Chloride Injection-250 mL, Rx Only Total Dose: (500 mcg/312.5 mg)/250…
FDA Drug · Class II · 2019-10-30 · Nephron Pharmaceuticals - PF-Fentanyl Citrate 2 mcg/mL* & Ropivacaine HCl 0.1% in 0.9% Sodium Chloride Injection-200 mL Total Dose: (400 mcg/200 mg)/200 mL, Rx Only…
FDA Drug · Class II · 2019-10-30 · Nephron Pharmaceuticals - del Nido Cardioplegia Solution, 1000 mL, Single-Dose Container, Rx Only Nephron 503B Outsourcing Facility 4500 12th St. Extension West Colu…
FDA Drug · Class II · 2019-10-30 · Nephron Pharmaceuticals
All Nephron Pharmaceuticals recalls
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0150-2020%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.